Cancer Monoclonal Antibodies Market Forecast to 2017SYS-CON Media (press release)Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 Million by 2020. The drama…
Cancer Monoclonal Antibodies Market Forecast to 2017PR Newswire UK (press release)Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 Million by 2020. The dram…
|
Biosimilar and Biosuperior Therapeutic Antibodies 2014
PR Carbon (press release) FOR IMMEDIATE RELEASE, Illinois – United States – March 13,2014 (PR Carbon):Reportstack has announced a new market research publication on Biosimilar and Biosuperior Therapeutic Antibodies 2014 which provides a competitor evaluation in the field … |
Vaccine News Daily |
Rare Double Infection: Lupus Patient Makes Antibodies to Fight HIV
Yahoo News The researchers found that in response to her HIV, the woman’s immune system produced what are called “broadly neutralizing antibodies,” which are effective in controlling HIV. Very few people infected with HIV create these antibodies, because the … Lupus Patient Makes Antibodies To Fight HIVHuffington Post Unique Individual Demonstrates Desired Immune Response to HIV VirusHealthCanal.com Seattle BioMed receives $9.8 million grant for HIV vaccineVaccine News Daily |
Vaccine News Daily |
Lupus Patient Makes Antibodies To Fight HIV
Huffington Post “We found that the patient did indeed make these important antibodies, and by determining how this immune response occurred, we have enhanced our understanding of the process involved,” said study researcher Dr. Barton Haynes, director of the Duke … Unique Individual Demonstrates Desired Immune Response to HIV VirusHealthCanal.com Seattle BioMed receives $9.8 million grant for HIV vaccineVaccine News Daily |
|
Interleukin-Antagonisten: Hoch effektiv gegen Entzündungen
Pharmazeutische Zeitung online … eines Transplantats innerhalb der ersten zehn Tage nach der Operation sind vor allem die zytotoxischen T-Lymphozyten verantwortlich. In Kombination mit anderen Immunsuppressiva soll Basiliximab die Abstoßung einer transplantierten Niere verhindern. |
Affinity Biologicals Inc. Has Become a Primary Manufacturer of Polyclonal …PR.com (press release)Affinity Biologicals, the Ontario-based company has gradually become the primary manufacturer of Hemostasis & Thrombosis related polyclonal antibodie…
LiveScience.com |
Rare Double Infection: Lupus Patient Makes Antibodies to Fight HIV
LiveScience.com One woman’s uncommon ability to fight her HIV infection may provide new insights for developing a vaccine that triggers a special immune response against the viral disease, researchers said. Scientists studied a 33-year old woman who had a rare … Unique Individual Demonstrates Desired Immune Response to HIV VirusNewswise (press release) A Person With Lupus Might Hold the Key to Developing An HIV VaccineMotherboard |
Research and Markets: The Cancer Monoclonal Antibodies Market is Estimated …Business Wire (press release)Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 …
|
A Person With Lupus Might Hold the Key to Developing An HIV Vaccine
Motherboard Generally, you don’t want to contract another serious autoimmune disease when you’re already HIV-positive. But it turns out that a patient with the extremely rare combination of both lupus and HIV is creating antibodies that might one day lead to an … |